Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium

被引:346
作者
Humby, Frances [1 ]
Bombardieri, Michele [1 ]
Manzo, Antonio [1 ]
Kelly, Stephen [1 ]
Blades, Mark C. [1 ]
Kirkham, Bruce [2 ]
Spencer, Jo [3 ]
Pitzalis, Costantino [1 ]
机构
[1] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England
[2] Kings Coll London, Guys Hosp, Dept Rheumatol, London WC2R 2LS, England
[3] Kings Coll London, Guys Hosp, Div Infect Immun & Inflammatory Dis, London WC2R 2LS, England
来源
PLOS MEDICINE | 2009年 / 6卷 / 01期
关键词
INDUCED CYTIDINE DEAMINASE; CITRULLINATED PEPTIDE ANTIBODIES; LARGE B-CELLS; ARTHRITIS-SPECIFIC AUTOANTIBODIES; SJOGRENS-SYNDROME; ANTIFILAGGRIN AUTOANTIBODIES; ANTIKERATIN ANTIBODIES; ANTIPERINUCLEAR FACTOR; SOMATIC HYPERMUTATION; NONLYMPHOID TISSUE;
D O I
10.1371/journal.pmed.0060001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Follicular structures resembling germinal centres (GCs) that are characterized by follicular dendritic cell (FDC) networks have long been recognized in chronically inflamed tissues in autoimmune diseases, including the synovium of rheumatoid arthritis (RA). However, it is debated whether these ectopic structures promote autoimmunity and chronic inflammation driving the production of pathogenic autoantibodies. Anti-citrullinated protein/peptide antibodies (ACPA) are highly specific markers of RA, predict a poor prognosis, and have been suggested to be pathogenic. Therefore, the main study objectives were to determine whether ectopic lymphoid structures in RA synovium: (i) express activation-induced cytidine deaminase (AID), the enzyme required for somatic hypermutation and class-switch recombination (CSR) of lg genes; (ii) support ongoing CSR and ACPA production; and (iii) remain functional in a RA/severe combined immunodeficiency (SCID) chimera model devoid of new immune cell influx into the synovium. Methods and Findings Using immunohistochemistry (IHC) and quantitative Taqman real-time PCR (QT-PCR) in synovial tissue from 55 patients with RA, we demonstrated that FDC+ structures invariably expressed AID with a distribution resembling secondary lymphoid organs. Further, AID+/CD21+ follicular structures were surrounded by ACPA+/CD138+ plasma cells, as demonstrated by immune reactivity to citrullinated fibrinogen. Moreover, we identified a novel subset of synovial AID+/CD20+ B cells outside GCs resembling interfollicular large B cells. In order to gain direct functional evidence that AID+ structures support CSR and in situ manufacturing of class-switched ACPA, 34 SCID mice were transplanted with RA synovium and humanely killed at 4 wk for harvesting of transplants and sera. Persistent expression of AID and I gamma-C mu circular transcripts (identifying ongoing IgM-IgG class-switching) was observed in synovial grafts expressing FDCs/CD21L. Furthermore, synovial mRNA levels of AID were closely associated with circulating human IgG ACPA in mouse sera. Finally, the survival and proliferation of functional B cell niches was associated with persistent overexpression of genes regulating ectopic lymphoneogenesis. Conclusions Our demonstration that FDC+ follicular units invariably express AID and are surrounded by ACPA-producing plasma cells provides strong evidence that ectopic lymphoid structures in the RA synovium are functional and support autoantibody production. This concept is further confirmed by evidence of sustained AID expression, B cell proliferation, ongoing CSR, and production of human IgG ACPA from GC+ synovial tissue transplanted into SCID mice, independently of new B cell influx from the systemic circulation. These data identify AID as a potential therapeutic target in RA and suggest that survival of functional synovial B cell niches may profoundly influence chronic inflammation, autoimmunity, and response to B cell depleting therapies.
引用
收藏
页码:59 / 75
页数:17
相关论文
共 60 条
  • [1] Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement
    Alessandri, C
    Bombardieri, M
    Papa, N
    Cinquini, M
    Magrini, L
    Tincani, A
    Valesini, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (10) : 1218 - 1221
  • [2] Lymphoid neogenesis in chronic inflammatory diseases
    Aloisi, F
    Pujol-Borrell, R
    [J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (03) : 205 - 217
  • [3] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
    ARNETT, FC
    EDWORTHY, SM
    BLOCH, DA
    MCSHANE, DJ
    FRIES, JF
    COOPER, NS
    HEALEY, LA
    KAPLAN, SR
    LIANG, MH
    LUTHRA, HS
    MEDSGER, TA
    MITCHELL, DM
    NEUSTADT, DH
    PINALS, RS
    SCHALLER, JG
    SHARP, JT
    WILDER, RL
    HUNDER, GG
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (03): : 315 - 324
  • [4] Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review
    Avouac, J.
    Gossec, L.
    Dougados, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) : 845 - 851
  • [5] Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome
    Barone, F
    Bombardieri, M
    Manzo, A
    Blades, MC
    Morgan, PR
    Challacombe, SJ
    Valesini, G
    Pitzalis, C
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (06): : 1773 - 1784
  • [6] A germinal center-like reaction in the nonlymphoid tissue of the synovial membrane
    Berek, C
    Schroder, AE
    [J]. B LYMPHOCYTES AND AUTOIMMUNITY, 1997, 815 : 211 - 217
  • [7] Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome
    Bombardieri, Michele
    Barone, Francesca
    Humby, Frances
    Kelly, Stephen
    McGurk, Mark
    Morgan, Peter
    Challacombe, Stephen
    De Vita, Salvatore
    Valesini, Guido
    Spencer, Jo
    Pitzalis, Costantino
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 179 (07) : 4929 - 4938
  • [8] Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response
    Breedveld, Ferdinand
    Agarwal, Sunil
    Yin, Ming
    Ren, Song
    Li, Nicole F.
    Shaw, Tim M.
    Davies, Brian E.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09) : 1119 - 1128
  • [9] The sense of coherence scale in patients with rheumatoid arthritis
    Callahan, LF
    Pincus, T
    [J]. ARTHRITIS CARE AND RESEARCH, 1995, 8 (01): : 28 - 35
  • [10] Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
    Cambridge, G
    Leandro, MJ
    Edwards, JCW
    Ehrenstein, MR
    Salden, M
    Bodman-Smith, M
    Webster, ADB
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (08): : 2146 - 2154